Get started
Author

Ioannis Vardakas

Observed name: Vardakas, Ioannis
ORCID: 0009-0005-5443-1142
Observed ORCID: 0009-0005-5443-1142
OpenAlex ID: A5093477042
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD
2023 · Ankelien Duchow, Judith Bellmann‐Strobl, et al. · Annals of Neurology · 72
PDF
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks
2024 · Carolin Schwake, Theodoros Ladopoulos, et al. · Journal of Neurology Neurosurgery & Psychiatry · 31
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis
2025 · Ahmed Abdelhak, Franziska Bachhuber, et al. · Journal of Neurology Neurosurgery & Psychiatry · 20
PDF
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study
2024 · Antonios Bayas, Ulrich Mansmann, et al. · Neurological Research and Practice · 10
PDF
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses
2024 · Ioannis Vardakas, Johannes Dorst, et al. · European Journal of Neurology · 7
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and vision
2024 · Mihaela Nicolescu, Vivien Häußler, et al. · Journal of Neurology · 5
Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple Sclerosis
2025 · Luisa T. Balz, Ingo Uttner, et al. · Biomedicines · 2
PDF
Plasma Exchange vs. Immunoadsorption: Effects on Immunological Markers and Predictive Value in Steroid-Refractory MS Attacks
2025 · Ioannis Vardakas, Johannes Dorst, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4 ‐ IgG + NMOSD Treated With Rituximab—A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group ( NEMOS )
2026 · Daniel Engels, Mariella Herfurth, et al. · European Journal of Neurology · 1
PDF
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD
2026 · Daniel Engels, Patrick Schindler, et al. · Neurology
Cognition and fatigue in clinically stable multiple sclerosis: EDSS and MRI metrics outperform serum biomarkers
2026 · Deborah K. Erhart, Luisa T. Balz, et al. · BMC Neurology
Cognition and fatigue in clinically stable multiple sclerosis: EDSS and MRI metrics outperform serum biomarkers
2026 · Erhart, Deborah K., Balz, Luisa T., et al. · Figshare
Additional file 1 of Cognition and fatigue in clinically stable multiple sclerosis: EDSS and MRI metrics outperform serum biomarkers
2026 · Erhart, Deborah K., Balz, Luisa T., et al. · Figshare
Prognostic value of evoked potentials for disease progression in early multiple sclerosis and clinically isolated syndrome in the prospective multicentre ProVal-MS study
2026 · Marie Braun, Joachim Havla, et al. · Clinical Neurophysiology
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study
2026 · Engels, Daniel, Schindler, Patrick, et al. · Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Quality of Life in Multiple Sclerosis Compared to Amyotrophic Lateral Sclerosis: Fatigue and Fast Disease Progression Interferes with the Ability to Psychosocially Adjust
2025 · Luisa T. Balz, Ingo Uttner, et al. · Brain Sciences
PDF
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study
2025 · Stefan Buchka, Alexander Hapfelmeier, et al. · Therapeutic Advances in Neurological Disorders
GFAP Levels Predict Response to Apheresis in Steroid-Refractory MS Relapses – A Subanalysis of the IAPEMS Trial
2024 · Ioannis Vardakas, Johannes Dorst, et al. · SSRN Electronic Journal
Works count: 21
Citation count: 154
H-index: 5
I10-index: 4
Year
Topic
Type